{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:05:18Z","timestamp":1790719518204,"version":"4.1.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T00:00:00Z","timestamp":1533340800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"IAME Research Group","award":["UMR 1137 INSERM"],"award-info":[{"award-number":["UMR 1137 INSERM"]}]},{"DOI":"10.13039\/501100005736","name":"Universit\u00e9 Paris Diderot","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005736","id-type":"DOI","asserted-by":"crossref"}]},{"name":"pour la Recherche M\u00e9dicale","award":["FRM 2016"],"award-info":[{"award-number":["FRM 2016"]}]},{"name":"pour la Recherche M\u00e9dicale","award":["DEQ20161136698"],"award-info":[{"award-number":["DEQ20161136698"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1093\/jac\/dky283","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T22:41:37Z","timestamp":1532040097000},"page":"3074-3080","source":"Crossref","is-referenced-by-count":21,"title":["Activity of fosfomycin alone or combined with temocillin in vitro and in a murine model of peritonitis due to KPC-3- or OXA-48-producing Escherichia coli"],"prefix":"10.1093","volume":"73","author":[{"given":"M","family":"Berleur","sequence":"first","affiliation":[{"name":"IAME, UMR1137, INSERM and Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Gu\u00e9rin","sequence":"additional","affiliation":[{"name":"CHU de Caen, Service de Microbiologie, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Massias","sequence":"additional","affiliation":[{"name":"AP-HP, Groupe Hospitalier Paris Nord Val de Seine, Pharmacie, H\u00f4pital Bichat, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Chau","sequence":"additional","affiliation":[{"name":"IAME, UMR1137, INSERM and Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Poujade","sequence":"additional","affiliation":[{"name":"IAME, UMR1137, INSERM and Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Cattoir","sequence":"additional","affiliation":[{"name":"CHU de Rennes, Service de Bact\u00e9riologie-Hygi\u00e8ne Hospitali\u00e8re, Rennes, France"},{"name":"CNR de la R\u00e9sistance aux Antibiotiques (laboratoire associ\u00e9 \u201cEnt\u00e9rocoques\u201d), Rennes, France"},{"name":"Universit\u00e9 de Rennes 1, Unit\u00e9 Inserm U1230, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Fantin","sequence":"additional","affiliation":[{"name":"IAME, UMR1137, INSERM and Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, Paris, France"},{"name":"AP-HP, Groupe Hospitalier Paris Nord Val de Seine, Service de m\u00e9decine interne, Clichy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"de Lastours","sequence":"additional","affiliation":[{"name":"IAME, UMR1137, INSERM and Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, Paris, France"},{"name":"AP-HP, Groupe Hospitalier Paris Nord Val de Seine, Service de m\u00e9decine interne, Clichy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"key":"key\n\t\t\t\t20181023055722125_dky283-B1","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace","volume":"215","author":"Logan","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/1469-0691.12719","article-title":"The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide","volume":"20","author":"Nordmann","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","article-title":"Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases","volume":"13","author":"Munoz-Price","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B4","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.cmi.2016.01.016","article-title":"Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae","volume":"22","author":"Falcone","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B5","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/cid\/cis588","article-title":"Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy","volume":"55","author":"Tumbarello","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B6","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1473-3099(17)30521-2","article-title":"Combination therapy for bloodstream infections with carbapenemase-producing Enterobacteriaceae","volume":"17","author":"Salzberger","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","article-title":"Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum \u03b2-lactamase producing, Enterobacteriaceae infections: a systematic review","volume":"10","author":"Falagas","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jac\/dkr466","article-title":"Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens","volume":"67","author":"Karageorgopoulos","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B9","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ijmm.2017.09.019","article-title":"Biological cost of fosfomycin resistance in Escherichia coli in a murine model of urinary tract infection","volume":"307","author":"Pourbaix","year":"2017","journal-title":"Int J Med Microbiol"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B10","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1128\/AAC.47.9.2850-2858.2003","article-title":"Biological costs and mechanisms of fosfomycin resistance in Escherichia coli","volume":"47","author":"Nilsson","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B11","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1128\/AAC.01086-10","article-title":"In vitro interactions of antimicrobial combinations with fosfomycin against KPC-2-producing Klebsiella pneumoniae and protection of resistance development","volume":"55","author":"Souli","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1128\/AAC.22.3.453","article-title":"Antibacterial activity and \u03b2-lactamase stability of temocillin","volume":"22","author":"Jules","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40262-017-0584-7","article-title":"Pharmacokinetics and pharmacodynamics of temocillin","volume":"57","author":"Alexandre","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B14","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1093\/jac\/dkw066","article-title":"Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producing Escherichia coli","volume":"71","author":"Alexandre","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/infdis\/137.2.122","article-title":"A method for testing for synergy with any number of agents","volume":"137","author":"Berenbaum","year":"1978","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0031-6997(25)00026-2","article-title":"What is synergy?","volume":"41","author":"Berenbaum","year":"1989","journal-title":"Pharmacol Rev"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijantimicag.2013.12.001","article-title":"Activity of fosfomycin alone or combined with cefoxitin in vitro and in vivo in a murine model of urinary tract infection due to Escherichia coli harbouring CTX-M-15-type extended-spectrum \u03b2-lactamase","volume":"43","author":"Lefort","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B18","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1128\/AAC.06233-11","article-title":"Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum \u03b2-lactamase","volume":"56","author":"Lepeule","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B19","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/jac\/dku542","article-title":"Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15","volume":"70","author":"Soubirou","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1128\/AAC.36.5.907","article-title":"In vivo antibiotic synergism: contribution of animal models","volume":"36","author":"Fantin","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(16)30257-2","article-title":"Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study","volume":"17","author":"Grundmann","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B22","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cmi.2015.05.022","article-title":"Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin","volume":"21","author":"Giske","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2217\/fmb.11.49","article-title":"Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes","volume":"6","author":"Falagas","year":"2011","journal-title":"Future Microbiol"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijantimicag.2011.01.012","article-title":"What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline","volume":"37","author":"Livermore","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20181023055722125_dky283-B25","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.clinthera.2012.05.002","article-title":"Treatment and clinical outcomes of urinary tract infections caused by KPC-producing Enterobacteriaceae in a retrospective cohort","volume":"34","author":"Alexander","year":"2012","journal-title":"Clin Ther"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/11\/3074\/26144676\/dky283.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T22:24:19Z","timestamp":1751754259000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/11\/3074\/5066451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,3]]},"references-count":25,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,8,3]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky283","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,8,3]]}}}